Can an MRI tell if a tumor is benign or malignant?

Not with certainty. MRI shows features that raise or lower suspicion, such as irregular borders or strong contrast uptake. Inflammation, scar tissue, and blood can mimic cancer on the images. A biopsy read by a pathologist is the only way to confirm the tumor type in most cases.

Does a normal MRI mean I do not have cancer?

A normal MRI is reassuring for the body part scanned, but it is not a guarantee. MRI images the region the doctor ordered, not the whole body. Very small tumors and cancers in air-filled organs like the lungs can be missed. Keep up with recommended screening tests such as mammograms and colonoscopy.

What does a PI-RADS 3 score on a prostate MRI mean?

PI-RADS 3 means intermediate or undetermined likelihood of clinically significant prostate cancer. It is the middle of a 1 to 5 scale. Your urologist will weigh the score with PSA level, prostate size, and family history. Some men with PI-RADS 3 have a targeted biopsy, and others are rechecked with a repeat MRI.

Is MRI or CT better for finding cancer?

Neither is better for every cancer. MRI gives more detail in soft tissue, so it leads for brain, prostate, liver, rectal, and musculoskeletal tumors. CT is faster and better for the lungs and for surveying the chest and abdomen. Doctors often use both, and PET/CT when the question is whether cancer has spread.

Why does my MRI report say a finding is indeterminate?

Indeterminate means the radiologist could not classify the finding as clearly benign or clearly suspicious from the images alone. It does not mean cancer is likely. The usual next step is a targeted scan, a short-interval follow-up MRI, or a biopsy, depending on the location and your risk factors.

Can an MRI Detect Cancer?

The short answer: Yes, an MRI can find many cancers. It is the standard imaging test for tumors of the brain, prostate, liver, rectum, and soft tissue, and for breast screening in high-risk women. But an MRI cannot confirm cancer on its own. The National Cancer Institute says doctors need a biopsy in most cases to be certain. A suspicious MRI is the start of a workup, not a diagnosis.

What does an MRI actually show?

An MRI uses a strong magnet and radio waves to build detailed pictures in slices. It does not use ionizing radiation. The NIH National Institute of Biomedical Imaging and Bioengineering says MRI scanners are "particularly well suited to image the non-bony parts or soft tissues of the body." That includes the brain, spinal cord, nerves, muscles, and organs.

Tumors are soft tissue, so MRI often shows them well. RadiologyInfo.org, the patient site of the ACR and RSNA, notes that MR images of the liver and other organs "are sometimes more likely to accurately identify disease than other imaging methods." The radiologist looks at the size, shape, borders, and blood supply of any mass. For how MRI and CT differ, see MRI vs CT scan.

Can an MRI diagnose cancer on its own?

Usually not. The National Cancer Institute states: "In most cases, doctors need to do a biopsy to be certain that you have cancer." A pathologist examines the tissue under a microscope.

MRI has real limits. RadiologyInfo.org notes that prostate MRI "cannot always distinguish between cancer and inflammation or the presence of blood products." The American Cancer Society says breast MRI "is more likely to find things that turn out not to be cancer, called false positives." That is why reports use words like "suspicious," "indeterminate," or "likely benign" rather than "cancer."

Liver cancer is a notable exception. The NCI says "a biopsy is not always needed to diagnose liver cancer. Sometimes the doctors can diagnose liver cancer based on the results of imaging tests such as CT scans and MRI."

Which cancers is MRI the standard test for?

Brain tumors. The NCI lists MRI with gadolinium as a core test. The contrast "collects around the cancer cells so they show up brighter in the picture." RadiologyInfo.org adds that MRI "can detect abnormalities that might be obscured by bone with other imaging methods."
Prostate cancer. Multiparametric MRI measures water diffusion and blood flow in the gland. Radiologists score each suspicious area with PI-RADS, from 1 (very low) to 5 (very high) likelihood of significant cancer. In the STHLM3-MRI trial cited by the NCI, 1,532 men were randomized. Benign biopsies fell to 11% in the MRI-guided group versus 43% with standard biopsy. The MRI group had 48% fewer biopsies and still found slightly more clinically significant cancers (21% versus 18%).
Breast cancer in high-risk women. The ACS recommends a yearly breast MRI plus mammogram, usually starting at age 30, for women with a lifetime risk of about 20% to 25% or greater, a known BRCA1 or BRCA2 change, or chest radiation before age 30. MRI is not recommended alone for average-risk women because "it can miss some cancers that a mammogram would find." Screening guidance for everyone else lives at mammogram.md.
Rectal cancer staging. The NCI physician guide uses MRI to measure how deep the tumor goes and whether surgery can get clear margins. Accuracy is 75% to 85% for tumor depth and 60% to 70% for lymph nodes.
Soft-tissue sarcoma and spine. The NCI says sarcoma "is diagnosed with a biopsy," and MRI or CT often guides the needle. MRI is also the preferred test for the spinal cord.

When is CT or PET a better choice?

MRI is not the best tool for every cancer. Lung tissue is full of air, which MRI images poorly. Lung screening uses low-dose CT. In the National Lung Screening Trial of 53,454 heavy smokers, low-dose CT cut the risk of dying from lung cancer by 15 to 20 percent compared with chest x-ray.

PET scans answer a different question: has the cancer spread? A PET scan uses a sugar-like tracer called FDG. "Cancer cells are more metabolically active and may absorb glucose at a higher rate," so they light up. Doctors use PET to "determine whether a cancer has spread in the body" and to check for recurrence. Almost all PET scans today are combined PET/CT. Prostate MRI, for example, "cannot tell if a cancer has spread distantly into other organs outside the pelvis." CT or PET covers that gap.

Why does contrast matter for finding cancer?

Most cancer MRIs use a gadolinium contrast injection. Tumors grow leaky new blood vessels, so contrast pools in them and they appear brighter. The ACS says contrast "is necessary when breast MRI is being performed to detect cancer." Our guide to MRI with contrast covers the injection itself.

Gadolinium is safe for most people. RadiologyInfo.org says it is less likely to cause an allergic reaction than the iodine contrast used for CT, and "severe reactions are rare." Two cautions apply. The FDA label for Gadavist carries a boxed warning: gadolinium agents raise the risk of nephrogenic systemic fibrosis in patients with severe kidney disease (GFR below 30). The same label states gadolinium "is retained for months or years in several organs," including bone and brain, and that "consequences of gadolinium retention in the brain have not been established." Tell your imaging center about any kidney disease, pregnancy, or prior contrast reactions.

Should I get a whole-body MRI to screen for cancer?

Whole-body MRI is sold directly to consumers as a cancer screen. The evidence does not support it for people without symptoms or risk factors. On April 17, 2023, the American College of Radiology stated it "does not believe there is sufficient evidence to justify recommending total body screening" for people with no symptoms, risk factors, or family history. The ACR warned such scans lead to "numerous non-specific findings" and "unnecessary follow-up testing and procedures."

The numbers back that up. A 2019 systematic review of 12 studies and 5,373 asymptomatic adults found critical or indeterminate incidental findings in 32.1% of scans. The pooled false-positive rate was 16.0%. A 2018 BMJ meta-analysis of 27,643 participants found potentially serious incidental findings in 3.9% of brain and body MRIs, "but little is known of their health consequences." A 2026 meta-analysis in European Radiology of 9,024 people found a confirmed cancer detection rate of 1.57%. The authors concluded that modest detection, frequent incidental findings, and no long-term outcome data "limit its current clinical utility." If you are at high genetic risk, ask a doctor about a targeted screening plan instead.

What happens after a suspicious MRI?

The report. The radiologist describes the finding and often suggests a next step. Reports usually post within a business day; see how long MRI results take.
More imaging or a repeat scan. An indeterminate finding may get a targeted MRI, ultrasound, or CT. Some low-suspicion lesions are simply rechecked in a few months.
Biopsy. A needle removes a tissue sample, often guided by ultrasound, CT, or MRI. A pathologist confirms whether cancer is present and what type.
Staging. If cancer is confirmed, the NCI explains doctors assign a TNM stage: tumor size (T), lymph nodes (N), and metastasis (M). That step may use CT, PET, bone scan, or more MRI.

Many suspicious MRI findings turn out benign. Ask the ordering doctor two questions: what is the level of suspicion, and what is the plan to resolve it?

The bottom line

MRI is one of the best tools for seeing soft-tissue tumors in the brain, prostate, breast, liver, rectum, and spine. It can find cancer, guide biopsies, and measure how far a tumor reaches. It cannot confirm cancer by itself, and it is not the right test for lung cancer or for checking distant spread. Whole-body MRI screening in healthy people finds far more false alarms than cancers, and the ACR does not recommend it. If your MRI shows something suspicious, the path is clear: targeted imaging, biopsy, and staging.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk to the doctor who ordered your MRI about what your results mean and whether a biopsy or further imaging is needed.